Breaking News

Fujifilm to Merge Toyama Chemical & RI Pharma

Seeks to accelerate new drug development through the merger

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Fujifilm Holdings unveiled plans to merge Toyama Chemical, a company that conducts the research, development, manufacture, and sales of small molecule pharmaceutical products, and Fujifilm RI Pharma, a company that conducts the research, development, manufacture, and sales of radiopharmaceuticals, to form Fujifilm Toyama Chemical. The new company will be operational as of October 1, 2018 in order to accelerate the development of new diagnostic and therapeutic drugs.    In preparation for the ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters